menu
    • menu

    Company profile for Venus Remedies

    NEW Drugs in Dev: 10
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We have been committed to improving human lives since the inception of company. Today, Venus creates innovative medicines that help patients globally. For a quarter of a century, we have done the grunt work. We've consistently invested in R&D. We've innovated unique, patented products. We've painstakingly built up a team that's high on passion, persistence and the will to be different. In the process, we've met global benchmar...
    We have been committed to improving human lives since the inception of company. Today, Venus creates innovative medicines that help patients globally. For a quarter of a century, we have done the grunt work. We've consistently invested in R&D. We've innovated unique, patented products. We've painstakingly built up a team that's high on passion, persistence and the will to be different. In the process, we've met global benchmarks and attained worldwide recognition. And after 25 years of building the most robust foundation possible, We have arrived. Now, we're geared up for our second inning, with strategic plans, breakthrough products.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Venus Remediesindia-flag Flag
    Country
    Country
    India
    Address
    Address
    51-52, Industrial Area Phase-1, Panchkula, Haryana, 134113
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://venusremedies.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/venusremedies/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Venus Remedies Expands Latin America With Ceftriaxone Approval
    Venus Remedies Expands Latin America With Ceftriaxone Approval

    08 May 2026

    // EXPRESSPHARMA

    https://www.expresspharma.in/venus-remedies-receives-argentina-approval-for-ceftriaxone-expands-latin-america-presence/

    EXPRESSPHARMA
    08 May 2026
    Share Share
    Venus Remedies Secures 2nd FY25 PLI, Nears Full-Year Goal
    Venus Remedies Secures 2nd FY25 PLI, Nears Full-Year Goal

    29 Jan 2026

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/venus-remedies-bags-second-pli-disbursement-for-fy25-nears-full-year-incentive-18992

    INDPHARMAPOST
    29 Jan 2026
    Share Share
    Venus Remedies Receives Second PLI Incentive Disbursement
    Venus Remedies Receives Second PLI Incentive Disbursement

    27 Jan 2026

    // EXPRESSPHARMA

    https://www.expresspharma.in/venus-remedies-receives-second-pli-incentive-disbursement-reinforcing-manufacturing-strength/

    EXPRESSPHARMA
    27 Jan 2026
    Share Share
    Venus secures Marketing Authorization for Ceftazidime + Avibactam
    Venus secures Marketing Authorization for Ceftazidime + Avibactam

    17 Jan 2026

    // EXPRESSPHARMA

    https://www.expresspharma.in/venus-remedies-secures-marketing-authorization-for-ceftazidime-avibactam-in-indonesia/

    EXPRESSPHARMA
    17 Jan 2026
    Share Share
    Venus Remedies Receives Rs. 11 Crore Final Payment From Cipla
    Venus Remedies Receives Rs. 11 Crore Final Payment From Cipla

    09 Dec 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/venus-remedies-secures-final-rs-11-crore-payment-from-cipla-for-amr-drug-18495

    INDPHARMAPOST
    09 Dec 2025
    Share Share
    Venus Remedies Expands In ASEAN With NDA in Vietnam
    Venus Remedies Expands In ASEAN With NDA in Vietnam

    10 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/venus-remedies-expands-asean-presence-with-new-drug-approvals-in-vietnam-18198

    INDPHARMAPOST
    10 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search